FindTrial
Sign In

Comparing nebulised verses instilled ropivacaine for post operative pain relief in laparoscopic cholecystectomy

To compare the efficacy of intraperitoneal nebulization and instillation of ropivacine for postoperative pain relief in patients undergoing laparoscopic cholecystectomy : A randomized double blinded control study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100221
Enrollment
50
Registered
2026-01-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K819- Cholecystitis, unspecified Health Condition 2: O- Medical and Surgical Health Condition 3: O- Medical and Surgical

Interventions

Intervention1: Intraperitoneal nebulization: Nebulization with ropivacine intraperitoneal Intervention2: Instillation: Instillation with ropivacine Intervention3: nebulization of ropivacine intraperit

Sponsors

Dr Manjunath B
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA 1&2

Exclusion criteria

Exclusion criteria: 1. Patient refusal to give consent. 2. coexisting disease affecting clinical assessment, 3. history of substance abuse, 4. psychiatric illness, 5. hepatic/renal dysfunction, 6. patients on chronic pain treatment, 7. pregnant/lactating females, 8. Allergy to local anaesthetics 9. Patients receiving opioids for chronic analgesic therapy 10. Coagulopathy

Design outcomes

Primary

MeasureTime frame
Intraperitoneal nebulization offers enhanced postoperative pain relief, reduced opioid consumption for patients undergoing laparoscopic cholecystectomy Timepoint: For 24 hours—

Secondary

MeasureTime frame
Intraperitoneal nebulization offers enhanced decrease in referred shoulder pain for patients undergoing laparoscopic CholecystectomyTimepoint: For 24 hrs—

Countries

India

Contacts

Public ContactDr Manjunath B

Kempegowda institute of medical sciences and research center

manjunath0993@gmail.com9480013943

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026